Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis
Idiopathic pulmonary fibrosis is a devastating aging-associated disease of unknown etiology. Despite that aging is a major risk factor, the mechanisms linking aging with this disease are uncertain, and experimental models to explore them in lung fibrosis are scanty. We examined the fibrotic response...
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | México |
| Institución: | Instituto Nacional de Medicina Genómica |
| Repositorio: | Repositorio del Instituto Nacional de Medicina Genómica |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.inmegen.gob.mx:274 |
| Acceso en línea: | http://repositorio.inmegen.gob.mx/record/274 |
| Access Level: | acceso abierto |
| Palabra clave: | info:eu-repo/classification/cti/3 |
| id |
MX_8cccbbc8d02a3c7700afb48d75f2b408 |
|---|---|
| oai_identifier_str |
oai:repositorio.inmegen.gob.mx:274 |
| network_acronym_str |
MX |
| network_name_str |
México |
| repository_id_str |
|
| spelling |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosisVILMA ARACELI MALDONADO LAGUNASinfo:eu-repo/classification/cti/3 Idiopathic pulmonary fibrosis is a devastating aging-associated disease of unknown etiology. Despite that aging is a major risk factor, the mechanisms linking aging with this disease are uncertain, and experimental models to explore them in lung fibrosis are scanty. We examined the fibrotic response to bleomycin-induced lung injury in Zmpste24-deficient mice, which exhibit nuclear lamina defects developing accelerated aging. We found that young WT and Zmpste24(-/-) mice developed a similar fibrotic response to bleomycin. Unexpectedly, while old WT mice developed severe lung fibrosis, accelerated aged Zmpste24-/- mice were protected showing scant lung damage. To investigate possible mechanisms associated with this resistance to fibrosis, we compared the transcriptome signature of the lungs and found that Zmpste24(-/-) mice showed downregulation of several core and associated matrisome genes compared with WT mice. Interestingly, some microRNAs that target extracellular matrix molecules such as miR23a, miR27a, miR29a, miR29b-1, miR145a, and miR491 were dysregulated resulting in downregulation of profibrotic pathways such as TGF-beta/SMAD3/NF-kappaB and Wnt3a/beta-catenin signaling axis. These results indicate that the absence of Zmpste24 in aging mice results in impaired lung fibrotic response after injury, which is likely associated to the dysregulation of fibrosis-related miRNAs. Aging-US2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://repositorio.inmegen.gob.mx/record/274reponame:Repositorio del Instituto Nacional de Medicina Genómicainstname:Instituto Nacional de Medicina Genómicainstacron:INMIGENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0oai:repositorio.inmegen.gob.mx:2742024-08-28T06:40:10Z |
| dc.title.none.fl_str_mv |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| title |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| spellingShingle |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis VILMA ARACELI MALDONADO LAGUNAS info:eu-repo/classification/cti/3 |
| title_short |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| title_full |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| title_fullStr |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| title_full_unstemmed |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| title_sort |
Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis |
| dc.creator.none.fl_str_mv |
VILMA ARACELI MALDONADO LAGUNAS |
| author |
VILMA ARACELI MALDONADO LAGUNAS |
| author_facet |
VILMA ARACELI MALDONADO LAGUNAS |
| author_role |
author |
| dc.subject.none.fl_str_mv |
info:eu-repo/classification/cti/3 |
| topic |
info:eu-repo/classification/cti/3 |
| description |
Idiopathic pulmonary fibrosis is a devastating aging-associated disease of unknown etiology. Despite that aging is a major risk factor, the mechanisms linking aging with this disease are uncertain, and experimental models to explore them in lung fibrosis are scanty. We examined the fibrotic response to bleomycin-induced lung injury in Zmpste24-deficient mice, which exhibit nuclear lamina defects developing accelerated aging. We found that young WT and Zmpste24(-/-) mice developed a similar fibrotic response to bleomycin. Unexpectedly, while old WT mice developed severe lung fibrosis, accelerated aged Zmpste24-/- mice were protected showing scant lung damage. To investigate possible mechanisms associated with this resistance to fibrosis, we compared the transcriptome signature of the lungs and found that Zmpste24(-/-) mice showed downregulation of several core and associated matrisome genes compared with WT mice. Interestingly, some microRNAs that target extracellular matrix molecules such as miR23a, miR27a, miR29a, miR29b-1, miR145a, and miR491 were dysregulated resulting in downregulation of profibrotic pathways such as TGF-beta/SMAD3/NF-kappaB and Wnt3a/beta-catenin signaling axis. These results indicate that the absence of Zmpste24 in aging mice results in impaired lung fibrotic response after injury, which is likely associated to the dysregulation of fibrosis-related miRNAs. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://repositorio.inmegen.gob.mx/record/274 |
| url |
http://repositorio.inmegen.gob.mx/record/274 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
| dc.format.none.fl_str_mv |
|
| dc.publisher.none.fl_str_mv |
Aging-US |
| publisher.none.fl_str_mv |
Aging-US |
| dc.source.none.fl_str_mv |
reponame:Repositorio del Instituto Nacional de Medicina Genómica instname:Instituto Nacional de Medicina Genómica instacron:INMIGEN |
| instname_str |
Instituto Nacional de Medicina Genómica |
| instacron_str |
INMIGEN |
| institution |
INMIGEN |
| reponame_str |
Repositorio del Instituto Nacional de Medicina Genómica |
| collection |
Repositorio del Instituto Nacional de Medicina Genómica |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1858176064254115840 |
| score |
15,812429 |